Reich Kristian, Chief Scientific Officer at MoonLake Immunotherapeutics ($MLTX), sold shares on the open market twice in the last 365 days for a total of $3.0 million. His most recent sale occurred on December 9, 2025. These sales rank 2,711th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | A | Stock Option (Right to Buy) | 520342 | $0.00 | 520,342.0000 | 64,037,478 | 9999.99% | 0.81% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1052 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.00% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 35389 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.06% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 35389 | $0.00 | 3,009,940.0000 | 64,037,478 | 1.19% | 0.06% |
| Dec. 8, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 130000 | $15.08 | 3,047,459.0000 | 64,037,478 | 4.09% | 0.20% |
| Dec. 9, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 72908 | $14.43 | 2,974,551.0000 | 64,037,478 | 2.39% | 0.11% |
| Sept. 2, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 48978 | $0.00 | 35,389.0000 | 62,870,237 | 58.05% | 0.08% |
| Jan. 20, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1456 | $0.00 | 1,052.0000 | 62,870,237 | 58.05% | 0.00% |
| Sept. 2, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 48978 | $0.00 | 3,177,459.0000 | 62,870,237 | 1.57% | 0.08% |
| Feb. 27, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | A | Stock Option (Right to Buy) | 139273 | $0.00 | 139,273.0000 | 62,870,237 | 9999.99% | 0.22% |
| Jan. 20, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 3328 | $0.00 | 2,508.0000 | 62,870,237 | 57.03% | 0.01% |
| Jan. 20, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | D | Class C ordinary shares, par value $0.0001 per share | 111949 | $0.00 | 84,367.0000 | 62,870,237 | 57.02% | 0.18% |
| Jan. 20, 2025 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | C | Class A ordinary shares, par value $0.0001 per share | 111949 | $0.00 | 3,079,503.0000 | 62,870,237 | 3.77% | 0.18% |
| Feb. 27, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 29431 | $55.00 | 2,995,644.0000 | 49,122,534 | 0.97% | 0.06% |
| Feb. 28, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 28090 | $55.00 | 2,967,554.0000 | 49,122,534 | 0.94% | 0.06% |
| Feb. 28, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 31910 | $55.00 | 2,967,554.0000 | 49,122,534 | 1.06% | 0.06% |
| Feb. 27, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 29491 | $55.00 | 2,999,464.0000 | 49,122,534 | 0.97% | 0.06% |
| Feb. 20, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $57.43 | 3,087,045.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 21, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 569 | $55.30 | 3,086,476.0000 | 49,122,534 | 0.02% | 0.00% |
| Feb. 21, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 509 | $55.31 | 3,086,476.0000 | 49,122,534 | 0.02% | 0.00% |
| Feb. 20, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $57.45 | 3,086,985.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 16, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.15 | 3,107,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 16, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.15 | 3,107,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 15, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.16 | 3,117,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 15, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $60.17 | 3,117,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 14, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $62.43 | 3,127,554.0000 | 49,122,534 | 0.32% | 0.02% |
| Feb. 14, 2024 | MoonLake Immunotherapeutics | $MLTX | Reich Kristian | Chief Scientific Officer | S | Class A ordinary shares, par value $0.0001 per share | 10000 | $62.42 | 3,127,554.0000 | 49,122,534 | 0.32% | 0.02% |